Rare renal tumor: a case report of collecting duct carcinoma and literature review

Collecting duct carcinoma (CDC), also known as Bellini duct carcinoma, is an extremely rare and highly aggressive subtype of renal cell carcinoma. Most patients present with metastasis at the time of diagnosis, and the prognosis for CDC patients is generally poor. Surgery is the primary treatment approach. In this article, we report a case of CDC presenting primarily with hematuria and provide a comprehensive review of the published literature concerning its diagnosis, treatment, and prognosis. The aim is to enhance understanding of this rare renal malignancy by elucidating its clinical and pathological characteristics and supplementing relevant treatment experiences.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-03-05
DOI
https://doi.org/10.3389/fonc.2026.1674239
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rare renal tumor: a case report of collecting duct carcinoma and literature review

Yingfang Zhang, Tingting Yang, Guang Han, Cheng Zhu et al.
Frontiers in Oncology
Renal cell carcinoma treatment
article

Rare renal tumor: a case report of collecting duct carcinoma and literature review

Yingfang Zhang, Tingting Yang, Guang Han, Cheng Zhu, Huangyu Luo, Bo Yu, Zhong Tian, Ni Fu, Neng Zhang
article en

Abstract

Collecting duct carcinoma (CDC), also known as Bellini duct carcinoma, is an extremely rare and highly aggressive subtype of renal cell carcinoma. Most patients present with metastasis at the time of diagnosis, and the prognosis for CDC patients is generally poor. Surgery is the primary treatment approach. In this article, we report a case of CDC presenting primarily with hematuria and provide a comprehensive review of the published literature concerning its diagnosis, treatment, and prognosis. The aim is to enhance understanding of this rare renal malignancy by elucidating its clinical and pathological characteristics and supplementing relevant treatment experiences.

Frontiers in OncologyVol. 16
Zunyi Medical University (CN), Affiliated Hospital of Zunyi Medical College (CN)
Health Commission of Guizhou Province
No poverty
Openalex Percentile: Top 32%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.